Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

FGFR1 amplification + HR positive

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

2099; 5241; 2260

Related biomarkers:

FGFR1 amplification + HR positive	HER2 Negative Breast Cancer	FGFR1 amplification + HR positive	HER2 Negative Breast Cancer	E 3810 Sensitive: C3 – Early Trials E 3810 Sensitive : C3	E 3810 Sensitive: C3 – Early Trials E 3810 Sensitive : C3
FGFR1 amplification + HR positive	HER2 Negative Breast Cancer	FGFR1 amplification + HR positive	HER2 Negative Breast Cancer	palbociclib Resistant: C3 – Early Trials palbociclib Resistant : C3	palbociclib Resistant: C3 – Early Trials palbociclib Resistant : C3
FGFR1 amplification + HR positive	HER2 Negative Breast Cancer	FGFR1 amplification + HR positive	HER2 Negative Breast Cancer	futibatinib Sensitive: C3 – Early Trials futibatinib Sensitive : C3	futibatinib Sensitive: C3 – Early Trials futibatinib Sensitive : C3